• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

STUDY OF BINDING ABILITY OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES WITH PROTEIN

Research Project

Project/Area Number 08670540
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionSt.Marianna University School of Medicine

Principal Investigator

SHOJI Yoko  St.Marianna University School of Medicine Department of Microbiology, Assistant Professor, 医学部, 講師 (00235714)

Co-Investigator(Kenkyū-buntansha) MIZUSHIMA Yutaka  St.Marianna University School of Medicine Institute of Medical Science, Professo, 難病治療研究センター, 教授 (40010409)
SHIMADA Jingoro  St.Marianna University School of Medicine Department of Microbiology, Professor, 医学部, 教授 (50056701)
Project Period (FY) 1996 – 1998
Keywordsoligonucleotides / phosphorothioate / phosphodiester / anti-herpetic activities / cationic liposomes
Research Abstract

We've recognized that phosphorothioate oligonucleotides (S-ODN) showed potent anti-herpetic activities when target site was limited near the splicing site. It was implied that S-ODN interfered the conservative structure which could be essential for the splicing, thus showed potent anti-herpetic activities. This was one explanation why S-ODN targeted splicing site showed potent anti-herpetic activities. However, it has been reported that G rich sequences reveal sequence non-specific biological activities. S-ODN may reveal another mechanism which might be based on strong protein binding activities. S-ODN strongly bound to serum protein at the ratio of 86.6%, while 21.6% for phosphodiester oligonucleotides (D-ODN). Binding activities which directly bound to the virus was more than 50% for S-ODN, on the other hand it was less than 5% for D-ODN.
Thirteen mer S-ODN showed inhibitory effect on virus entry into the cell at the early stage of infection, while D-ODN did not. CD spectrum of S-ODN implied G-quartet structure, however, the relation between biological activities and higher dimension structure could not be clear.
Moreover, we tried to enhance the anti-herpetic activities of S-ODN by using cationic liposomes. Cationic liposomes is useful tool to enhance the anti-herpetic activities of D-ODN, while it was not the case for SOD.One of the reason might be strong protein binding activities of S-ODN.From this study, the caution is proposed when S-ODN containing G-rich sequences might involve another mechanism other than antisense manner. We should carefully select the drug delivery system to enhance the biological activities of S-ODN.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] 岩谷若夫、東海林洋子、他: "抗HSV活性を有するアンチセンス・オリゴDNAの安定性およびウイルス感染細胞における動態の検討" Drug Delivery System. 11. 427-434 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shoji Y.et al.: "Cellular uptake and biological effects of antisenese oligodeoxynucleotide analogs targeted to herpes simplex virus." Antimicrob. Agents Chem.40. 1670-1675 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 東海林洋子、他: "VEGF mRNAに対するヒト臍帯静脈細胞の管腔形成抑制の効果をカチオン性リポソームが増強" Drug Delivery System. 12. 187-192 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shoji Y.et al.: "Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5'end modified with geranoil." J.Drug Targeting. 5(4). 261-273 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 東海林洋子、他: "オリゴヌクレオチドの抗ヘルペス効果-PCR法による判定-" 日本化学療法学会誌. 46(9). 363-367 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shoji Y.et al.: "Limited usage of cationic liposomes as tools to enhance the anti-herpetic activities of oligonucleotides in Vero cells infected with herpes simplex virus type I" Antisense Nucleic Acid Drug Dev.8(4). 255-263 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shoji Y.et al.: "Anti-HIV activity of phosphorothioate oligodeoxynucleotides containing consecutive G sequences" Int.J.Immunotherapy. XII(1/2). 1-9 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shoji Y.et al.: "Cellular uptake and biological effects of antisense oligodexynucleotides analogs targeted to herpes simplex virus." Antimicrob.Agents Chem.40. 1670-1675 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shoji Y.et al.: "Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol." 23rd International Symposium on Controlled Release of Bioactive Materials.263-264 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato T., Shoji Y.et al.: "DNA hybrid complexes with glutamic acid derivatives and their applications to gene delivery system." 23rd International Symposium on Controlled Release of Bioactive Materials.895-896 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koyama Y., Shoji Y.et al.: "Novel poly (ethyleneglycol) derivatives having pendant amino groups : aggregation of its acids and amphiphilic polyion complex with fatty the application to DNA delivery." 23rd International Symposium on Controlled Release of Bioactive Materials.897-898 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shoji Y., et al.: "Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol." J.Drug Targeting. 5(4). 261-273 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shoji Y., et al.: "Limited usage of cationic liposomes as tools to enhance the anti-herpetic activities of oligonucleotides in Vero cells infected with herpes simplex virus type I." Antisense Nucleic Acid Drug Dev.8(4). 255-263 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shoji Y., et al.: "Characteristics of oligonucleotides entrapped into liposumal formulations." 25rd International Symposium on Controlled Release of Bioactive Materials.346-347 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi